HOME >> BIOLOGY >> NEWS
Identifying cancer genes Will it really lead to better treatment?

Copenhagen, Denmark: A systematic trawl through the human genome looking for the abnormalities that drive cancer is already producing promising results, a scientist told ECCO 12 The European Cancer Conference in Copenhagen today (Tuesday 23 September). Dr. Michael Stratton, Director of the Cancer Genome Project at the Wellcome Trust Sanger Institute, Cambridge, UK, described how his study of the BRAF mutation could provide new targets for drug development, which could lead to better targeted or even individualised - treatment for cancer patients.

The decoding of the human genome has allowed scientists to compare the normal DNA sequence with that seen in cancers, and hence identify abnormalities. The BRAF mutation is implicated in a number of common cancers, according to Dr. Stratton. It appears to be involved in the switching mechanism of the gene, and is found in 70% of melanomas, in 30% of some types of thyroid and ovarian cancer, and in 10% of colorectal tumours. Over 80% of the mutations bring about a single change in an amino acid, making it a relatively simple target for rectification. "Once we can identify this kind of abnormal biological process", said Dr. Stratton. "we can move on to the next stage developing drugs to prevent or correct it."

The traditional approach to research in cancer has been the comparison of treatments through randomised clinical trials, with the extrapolation of an average benefit to the individual. This often means that many patients are inefficiently treated, while only a few benefit. Gene targets herald a different approach, and are becoming increasingly important in the search for effective cancer treatments. Genes are implicated in cancer in a number of ways as oncogenes, which drive cancer forward, as tumour suppressor genes that slow down cell division, and as DNA repair genes, which help to keep chromosomes intact when genetic mutation occurs.

A small number of drugs targeted at mutated
'"/>

Contact: Margaret Willson
m.willson@mwcommunications.org.uk
45-3252-4179
Federation of European Cancer Societies
23-Sep-2003


Page: 1 2

Related biology news :

1. Identifying tick genes could halt disease, bioterrorism threat
2. Identifying individuals at risk for Alzheimers disease
3. Identifying novel small RNAs
4. Breakthrough in genomic technology: Identifying the biologically relevant parts of the human genome
5. Leader in cancer treatment and prevention research honored
6. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
7. Chemical derived from vitamin-E shows early promise as cancer drug
8. New molecular link key to cellular proteins involved in cancer progression, other diseases
9. Phase II trials of second-generation antisense cancer drug planned following successful early study
10. Trial shows which brain cancer patients benefit from temozolomide
11. Genetic differences might help distinguish thyroid cancers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2018)... ... August 21, 2018 , ... Whether it be ... is dedicated to offering customers a successful experience. When browsing the new ... transition between products, with relevant details such as technical manuals, application notes, and ...
(Date:8/17/2018)... CASTLE ROCK, Colo. (PRWEB) , ... August 16, 2018 , ... ... for facioscapulohumeral muscular dystrophy (FSHD), announced that its Colorado Chapter will be holding its ... event, scheduled for September 8th at the Philip S. Miller Park, advocates for public ...
(Date:8/15/2018)... ... 15, 2018 , ... The Florida Chiropractic Association’s National Meeting on ... Doctors from around the U.S. will gain firsthand insights into the new laser’s advancements ... completed another successful clinical trial that has resulted in the granting of an FDA ...
Breaking Biology News(10 mins):
(Date:8/31/2018)... ... , ... Small, wireless and networked describes more than the latest household gadget. ... latest system is tiny in size, but is poised to make a big impact ... implant design is the growing awareness that disease often involves complex interactions between multiple ...
(Date:8/29/2018)... POWAY, Calif. (PRWEB) , ... August 28, 2018 ... ... Harman, will be presenting the results of a safety study performed on an ... 2018 North American Veterinary Regenerative Medicine Association (NAVRMA) conference in September. He ...
(Date:8/26/2018)... ... August 24, 2018 , ... ExoCoBio Inc., based in South ... dermatitis and inhibits a variety of inflammatory targets in the journal of Stem ... mice having severe atopic dermatitis were significantly improved after administration of stem cell-derived ...
(Date:8/21/2018)... ... August 21, 2018 , ... The Connecticut Technology Council (CTC) and Marcum LLP ... growing technology companies in Connecticut. This year’s group of top-ranked companies will be honored ... the Connecticut Convention Center in Hartford. A complete list of the Marcum Tech Top ...
Breaking Biology Technology:
Cached News: